Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer

NCT00859703 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Menopause
Osteopenia

Interventions

DRUG: Risedronate
DRUG: Placebo

Sponsor

Hospices Civils de Lyon